|
Prediction of immunotherapy response by integrating immune infiltration and neoantigen presentation score in late-stage melanoma. |
| |
|
|
Stock and Other Ownership Interests - Personalis |
| |
|
|
Stock and Other Ownership Interests - Personalis |
| |
|
No Relationships to Disclose |
| |
|
|
Stock and Other Ownership Interests - Personalis |
| |
|
|
Stock and Other Ownership Interests - Personalis |
| |
|
|
Research Funding - Personalis |
| |
|
|
Stock and Other Ownership Interests - Personalis |
| |
|
|
Stock and Other Ownership Interests - Personalis |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Iovance Biotherapeutics; Macrogenics; Pfizer; Sanofi; Sun Biopharma |
| |
|
|
Stock and Other Ownership Interests - Personalis |
Patents, Royalties, Other Intellectual Property - I have patents though my position and work at Personalis, Inc. |
| |
|
|
|
Stock and Other Ownership Interests - Personalis |
Patents, Royalties, Other Intellectual Property - Personalis |
Travel, Accommodations, Expenses - Personalis |